- Home
- ACEL vs SGP Comparison
ACEL vs SGP Comparison
Compare ACEL & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | SGP |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.7M | 932.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACEL | SGP |
|---|---|---|
| Price | $11.04 | $22.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $14.67 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 363.3K | 107.1K |
| Earning Date | 05-04-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.34 | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $2.81 | N/A |
| P/E Ratio | $18.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.17 | $21.29 |
| 52 Week High | $13.31 | $30.56 |
Technical Indicators
Market Signals| Indicator | ACEL | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 38.68 |
| Support Level | $10.87 | $21.29 |
| Resistance Level | $11.59 | $29.83 |
| Average True Range (ATR) | 0.30 | 2.10 |
| MACD | -0.02 | -0.25 |
| Stochastic Oscillator | 48.43 | 16.93 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.